Serena Lembo

Prof. Serena Lembo


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
RCRoberta Di Caprio
Roberta Di Caprio
SLSerena Lembo
Serena Lembo
LCLuisa Di Costanzo
Luisa Di Costanzo
ABAnna Balato
Anna Balato
GMGiuseppe Monfrecola
Giuseppe Monfrecola
Doxycycline is used to treat infective diseases because of its broadspectrum efficacy. High dose administration (100 or 200 mg/day) is often responsible for development of bacterial resistances and endogenous flora alterations, whereas low doses (20–40 mg/day) do not alter bacteria susceptibility to antibiotics and exert anti‐inflammatory activities. In this study, we wanted to assess the efficacy of both low and high doxycycline doses in modulating IL‐8, TNF‐α, and IL‐6 gene expression in HaCaT cells stimulated with LPS. Three experimental settings were used, differing in the timing of doxycycline treatment in respect to the insult induced by LPS: pretreatment, concomitant, and posttreatment. Low doses were more effective than high doses in modulating gene expression of LPS‐induced proinflammatory cytokines (IL‐8, TNF‐α, and IL‐6), when added before (pretreatment) or after (posttreatment) LPS stimulation. This effect was not appreciated when LPS and doxycycline were simultaneously added to cell cultures: in this case high doses were more effective. In conclusion, our in vitro study suggests that low doxycycline doses could be safely used in chronic or acute skin diseases in which the inflammatory process, either constantly in progress or periodically recurring, has to be prevented or controlled.

3 December 2015 in Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
GMGiuseppe Monfrecola
Giuseppe Monfrecola
SLSerena Lembo
Serena Lembo
GCGiuseppina Caiazzo
Giuseppina Caiazzo
VVValerio De Vita
Valerio De Vita
RCRoberta Di Caprio
Roberta Di Caprio
GFGabriella Fabbrocini
Gabriella Fabbrocini

29 October 2021 in Dermatology Practical & Conceptual
Verified
Journal Article
Open access
PDF file
ARAnnunziata Raimondo
Annunziata Raimondo
SLSerena Lembo
Serena Lembo
Atopic dermatitis (AD) is a chronic, lifelong, relapsing condition. The wide spectrum of the possible clinical presentations, depending on patient’s age, age of onset of disease, topography and morphology of dermatitis, limits the epidemiologic information on its prevalence and incidence. A clear definition of the different clinical AD phenotypes and epidemiology is essential for an appropriate patient’s treatment and management, in particular for adults. This review summarizes the most recent epidemiologic data from the 21st century, on AD prevalence and incidence rates either in children or adults, with a special focus on their trends in Europe. Moreover, an effort to categorize diverse AD clinical expressions has been made, aiming to facilitate differential diagnosis and speed up the start of the correct therapy.

4 August 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
SLSerena Lembo
Serena Lembo
ABAnna Balato
Anna Balato
RCRoberta Di Caprio
Roberta Di Caprio
TCTeresa Cirillo
Teresa Cirillo
VGValentina Giannini
Valentina Giannini
GMGiuseppe Monfrecola
Giuseppe Monfrecola
Ultraviolet radiation (UV) induces an increase in multiple cutaneous inflammatory mediators. Ellagic acid (EA) and rosmarinic acid (RA) are natural anti-inflammatory and immunomodulatory compounds found in many plants, fruits, and nuts. We assessed the ability of EA and RA to modulate IL-1β, IL-6, IL-8, IL-10, MCP-1, and TNF-αgene expression in HaCaT cells after UVB irradiation. Cells were treated with UVB (100 mJ/cm2) and simultaneously with EA (5 μM in 0.1% DMSO) or RA (2.7 μM in 0.5% DMSO). Moreover, these substances were added to the UVB-irradiated cells 1 h or 6 h before harvesting, depending on the established UVB-induced cytokine expression peak. Cytokine gene expression was examined using quantitative real time polymerase chain reaction. RA produced a significant reduction in UVB-induced expression of IL-6, IL-8, MCP-1, and TNF-αwhen applied at the same time as irradiation. EA showed milder effects compared with RA, except for TNF-α. Both substances decreased IL-6 expression, also when applied 5 h after irradiation, and always produced a significant increase in UVB-induced IL-10 expression. Our findings suggest that EA and RA are able to prevent and/or limit the UVB-induced inflammatory cascade, through a reduction in proinflammatory mediators and the enhancement of IL-10, with its protective function.

12 February 2013 in Clinical and Experimental Dermatology
Verified
Journal Article
Closed access
PDF file
GMG. Monfrecola
G. Monfrecola
FGF. Gaudiello
F. Gaudiello
TCT. Cirillo
T. Cirillo
GFG. Fabbrocini
G. Fabbrocini
ABAnna Balato
Anna Balato
SLSerena Lembo
Serena Lembo

19 November 2008 in British Journal of Dermatology
Verified
Journal Article
Closed access
PDF file
SLSerena Lembo
Serena Lembo
JFJ. Fallon
J. Fallon
POP. O’kElly
P. O’kElly
GMG.M. Murphy
G.M. Murphy